ÂÜÀòÂÒÂ×

David Jung is an accomplished chemist with extensive experience in medicinal chemistry and drug development. Currently serving as a Chemist at SpringWorks Therapeutics since December 2023, David has previously held leadership roles at Agile Sciences since July 2015 and at KinoDyn, Inc. from July 2014 to July 2015. David's career includes significant contributions as a Research Chemist at RTI International, where the focus was on developing novel chemical classes for drug development. Additional experience encompasses positions at CoMentis and GlaxoSmithKline, with a strong foundation in synthetic chemistry established during a postdoctoral tenure at Memorial Sloan-Kettering Cancer Center. David earned a Ph.D. in Synthetic Organic Chemistry from the University of North Carolina at Chapel Hill.